In March 2025, the company declared new strategies for the immediate-to-consumer providing of its Wegovy weight loss drug. The company founded a new pharmacy, named NovoCare, which would demand consumers $499 per 30 days for entry to the drug, under half the expense of the drug by other pharmaceutical distribution networks.[53]In Oct 2024, Novo Nor